Found: 10
Select item for more details and to access through your institution.
The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease: The RISE-PD Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 10, p. 1062, doi. 10.1001/jamaneurol.2023.2679
- By:
- Publication type:
- Article
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2018, v. 75, n. 10, p. 1206, doi. 10.1001/jamaneurol.2018.1487
- By:
- Publication type:
- Article
Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information.
- Published in:
- Toxins, 2024, v. 16, n. 10, p. 442, doi. 10.3390/toxins16100442
- By:
- Publication type:
- Article
Single-Dose Administration of MK-0657, an NR2B-Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moderate Parkinson's Disease.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 7, p. 856, doi. 10.1177/0091270009336735
- By:
- Publication type:
- Article
Subcutaneous Levodopa Infusion for Parkinson's Disease: 1‐Year Data from the Open‐Label BeyoND Study.
- Published in:
- Movement Disorders, 2021, v. 36, n. 11, p. 2687, doi. 10.1002/mds.28758
- By:
- Publication type:
- Article
Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease.
- Published in:
- Movement Disorders, 2011, v. 26, n. 12, p. 2246, doi. 10.1002/mds.23861
- By:
- Publication type:
- Article
Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson's disease.
- Published in:
- Neuropsychiatric Disease & Treatment, 2018, v. 14, p. 839, doi. 10.2147/NDT.S153321
- By:
- Publication type:
- Article